Identical twin toddlers who presented with severe arthritis helped scientists to identify the first gene mutation that can single-handedly cause a juvenile form of this inflammatory joint disease. By investigating the DNA of individual blood cells of both children and then modelling the genetic defect in a mouse model, the research team led by Adrian Liston (VIB-KU Leuven) was able to unravel the disease mechanism. The findings may help to develop an appropriate treatment as well.
Juvenile idiopathic arthritis is the most common form of all childhood rheumatic diseases. It is defined as arthritis that starts at a young age and persists throughout adulthood, but which does not have a defined cause. Patients present with a highly variable clinical picture, and scientists have long suspected that different combinations of specific genetic susceptibilities and environmental triggers drive the disease.
A single gene mutation
In a new study by researchers at VIB, KU Leuven and UZ Leuven, the cause of juvenile arthritis in a young pair of identical twins was traced back to a single genetic mutation.
“Single-cell sequencing let us track what was going wrong in every cell type in the twin’s blood, creating a link from genetic mutation to disease onset,” explains Dr. Stephanie Humblet-Baron (VIB-KU Leuven), one of the researchers involved in the study. “It was the combination of next generation genetics and immunology approaches that allowed us to find out why these patients were developing arthritis at such a young age.”
Modelling a human disease in mice
Parallel studies in mice confirmed that the gene defect found in the patients’ blood cells indeed led to an enhanced susceptibility to arthritis. Prof. Susan Schlenner (VIB-KU Leuven), first author of the study, stresses the relevance of this approach: “New genetic editing approaches bring mouse research much closer to the patient. We can now rapidly produce new mouse models that reproduce human mutations in mice, allowing us to model the disease of individual patients.”
According to immunology prof. Adrian Liston (VIB-KU Leuven) such insights prove invaluable in biomedical research: “Understanding the cause of the disease unlocks the key to treating the patient.”
From cause to cure
Liston’s team collaborated closely with prof. Carine Wouters (UZ Leuven), who coordinated the clinical aspect of the research: “The identification of a single gene that can cause juvenile idiopathic arthritis is an important milestone. A parallel mouse model with the same genetic mutation is a great tool to dissect the disease mechanism in more detail and to develop more effective targeted therapies for this condition.”
And the young patients? They are relieved to know that scientists found the cause of their symptoms: “We are delighted to know that an explanation has been found for our illness and more so because we are sure it will help other children.”
Thankfully, the youngsters’ arthritis is under good control at th?e moment. Thanks to the new scientific findings, their doctors will be in a much better position to treat any future flare-ups.
The Latest on: Juvenile idiopathic arthritis
via Google News
The Latest on: Juvenile idiopathic arthritis
- Roche Announces Positive Late-Stage Data on Rituxan in PVon October 14, 2019 at 6:09 pm
Apart from Rituxan, Roche’s rheumatology portfolio has a first-in-class anti-IL-6 receptor therapy, Actemra/RoActemra. It is approved for RA, polyarticular and systemic juvenile idiopathic arthritis, ...
- St. John teen needs surgery for condition that causes jaw to dissolveon October 14, 2019 at 3:00 am
His parents thought it might be anxiety. In December, however, his oral surgeon said Camden's jaw had gotten so bad that the procedure couldn't wait. His juvenile idiopathic arthritis had caused a ...
- Children with arthritis lack vitamin Don October 13, 2019 at 12:13 pm
(MENAFN - The Conversation) In an analysis of global research, we recently found that children with the most frequent type of arthritis, juvenile idiopathic arthritis (JIA), haveabnormally low vitamin ...
- TNF Alpha Inhibitors Market By Drug Class, By Pipeline Analysis & By Regions - Global Forecast up to 2025 - ResearchAndMarkets.comon October 11, 2019 at 3:35 am
For instance, in July 2019, the US FDA approved HADLIMA by Samsung Bioepis, a biosimilar referencing HUMIRA, to treat juvenile idiopathic arthritis, adult Crohn's disease, psoriatic arthritis, ...
- Geraldine teenager living a normal life with arthritis from a young ageon October 10, 2019 at 9:17 pm
Arthritis affects more than 647,000 people in New Zealand, according to Ministry of Health data released in 2018, but there is no official data for the number of children who live with the condition.
- Kids risk permanent damage as juvenile arthritis is misdiagnosedon September 28, 2019 at 5:00 pm
“NSW Health was represented on the Steering Committee for the National Strategic Action Plan for Arthritis, which includes a number of strategies aimed at improving the care of children with Juvenile ...
- FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form ofon September 24, 2019 at 9:34 pm
Before it's here, it's on the Bloomberg Terminal.
- Juvenile Idiopathic Arthritison September 12, 2019 at 5:00 pm
The American College of Rheumatology has developed new guidelines for starting and monitoring treatments for children with juvenile idiopathic arthritis. These are the first JIA guidelines endorsed by ...
- Lethal Lung Disease and Biologics: Is There a Link?on September 4, 2019 at 9:05 am
A new, potentially life-threatening parenchymal lung disease is increasingly being detected in patients with systemic juvenile idiopathic arthritis (sJIA), according to recent reports. Systemic JIA is ...
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritison August 14, 2019 at 5:00 pm
Interleukin-1 is pivotal in the pathogenesis of systemic juvenile idiopathic arthritis (JIA). We assessed the efficacy and safety of canakinumab, a selective, fully human, anti–interleukin-1β ...
via Bing News